Fortress Biotech Inc logo

Fortress Biotech Inc

NAS:FBIO (USA)  
$ 2.17 0 (0%) 04:00 PM EST
At Loss
P/B:
1.16
Market Cap:
$ 39.88M
Enterprise V:
$ 33.40M
Volume:
2.47K
Avg Vol (2M):
318.41K
Also Trade In:
Volume:
2.47K
At Loss
Avg Vol (2M):
318.41K

Business Description

Description
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.
Name Current Vs Industry Vs History
Cash-To-Debt 1.03
Equity-to-Asset 0.11
Debt-to-Equity 4.21
Debt-to-EBITDA -0.44
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -9.4
Distress
Grey
Safe
Beneish M-Score -1.21
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 76.57
9-Day RSI 63.87
14-Day RSI 58.08
6-1 Month Momentum % -56.72
12-1 Month Momentum % -82.4

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1
Quick Ratio 0.89
Cash Ratio 0.74
Days Inventory 169.5
Days Sales Outstanding 98.34
Days Payable 700.57

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -14.3
Shareholder Yield % -164.05

Financials (Next Earnings Date:2024-05-15 Est.)

FBIO's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:FBIO

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Fortress Biotech Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 80.971
EPS (TTM) ($) -11.084
Beta 1.52
Volatility % 99.99
14-Day RSI 58.08
14-Day ATR ($) 0.177712
20-Day SMA ($) 2.02225
12-1 Month Momentum % -82.4
52-Week Range ($) 1.24 - 12.749999
Shares Outstanding (Mil) 18.38

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Fortress Biotech Inc Filings

Filing Date Document Date Form
No Filing Data

Fortress Biotech Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Fortress Biotech Inc Frequently Asked Questions

What is Fortress Biotech Inc(FBIO)'s stock price today?
The current price of FBIO is $2.17. The 52 week high of FBIO is $12.75 and 52 week low is $1.24.
When is next earnings date of Fortress Biotech Inc(FBIO)?
The next earnings date of Fortress Biotech Inc(FBIO) is 2024-05-15 Est..
Does Fortress Biotech Inc(FBIO) pay dividends? If so, how much?
Fortress Biotech Inc(FBIO) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1